Back

Effects and safety of beta-blocker withdrawal among patients undergoing transcatheter aortic valve replacement

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 6 - Clinical impact of intervention in valve disease Intervention ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Arwa Younis

University of Rochester, Rochester (United States of America)

8 More presentations in this session

Presentation thumbnail
Risk of major AV conduction disturbances after TAVR attributable to aortic calcium burden
Doctor P. Marcos-Alberca (Madrid, ES)
Abstract Slides
Presentation thumbnail
Reduction in sympathetic activity in patients with aortic stenosis after transcatheter aortic valve implantation
Associate Professor K. Mert (Eskisehir, TR)
Abstract Slides
Presentation thumbnail
Impact of the repositionable Evolut R CoreValve on the need for permanent pacemaker after transcatheter aortic valve implantation in patients with severe aortic stenosis
Professor M. Romero (Cordoba, ES)
Abstract Slides
Presentation thumbnail
Treatment of severe aortic stenosis by transcatheter aortic valve replacement (TAVR) is associated with a decrease of pre-existing depression and anxiety
Doctor G. Dannberg (Jena, DE)
Abstract
Presentation thumbnail
National trends, outcomes and complications of transcatheter pulmonary valve replacement; a population study
Doctor A. Tsangaris (Athens, GR)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 6 - Clinical impact of intervention in valve disease

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources